New Home Buyer Program for House Owners Looking to Sell in Olympia Washington

​ launches a house buying program for home owners in Olympia, Washington.

Lacey, United States - September 13, 2017 /PressCable/ — have recently launched a new house buying program in the city of Olympia, Washington. The program entails buying houses from home owners for fast cash. Unlike other programs, it’s geared towards helping home owners get cash from the sale of their houses as soon as possible, usually within days.

There’s a network of professional real estate investors behind the program who are ready to pay cash for any house, regardless of its condition. To get cash for a house, all a homeowner needs to do is give them a call, text them, or use the “Fast Cash Offer” button on their website to get an offer, and the transaction will be completed within days.

The real estate investors running the program pride themselves in making offers that are fair for both parties, so every homeowner gets their house’s worth after each successful sale. It’s not just fair, it also ensures that the homeowner gets the maximum amount of cash they could ever get from the sale of their home. In other words, they have unbeatable offers.

The business was founded on the premise of helping people get rid of their homes quickly so they can be put into good use. Many homeowners have houses left in limbo and serving no real purpose for reasons such as inability to find a tenant, serious damages that require massive expenses to get the house back to a livable condition, etc. In addition to that, some just have houses that they don’t need, for example, inherited properties. currently buys houses located in Governor Stevens, Northwest Olympia, South Westside, Castlewood, West Bay Drive, The Birches, Briarwood, Nottingham, Indian Creek, and many other areas in the city of Olympia, Washington.

Potential clients who seek more information can contact them through their website’s contact page or their phone number – 425-577-0105.

Contact Info:
Name: Jesse Herzog
Organization: We Buy Olympia Washington Houses
Address: 2622 Glen Terra Drive Southeast, Lacey, Washington 98503, United States
Phone: +1-425-577-0105

For more information, please visit

Source: PressCable

Release ID: 238977

Latest News

EU charges Merck KGaA, GE, Canon of misleading merger info

Nov 22, 2017

By Foo Yun CheeBRUSSELS (Reuters) - General Electric , German drugmaker Merck KGaA , and Japan's Canon risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals.The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules.While the charges will not affect the EU approvals of the deals, they could lead to fines up to 1 percent of global revenue for Merck KGaA and General Electric, and up to...

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Nov 22, 2017

By Sam NusseyTOKYO (Reuters) - Konica Minolta Inc said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the Japanese firm's healthcare business as it seeks a leading position in precision medicine.The deal is the largest ever for the photocopier maker, which has been seeking to diversify away its office equipment business. It pulled out of cameras about a decade ago.Konica Minolta said its advanced imaging technology complemented privately held Ambry's genetic testing capabilities, with initial applications for combining the technologies seen in...

Oxford BioMedica wins big contract for Novartis cell therapy

Nov 22, 2017

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.The deal, announced by Oxford BioMedica on Thursday, could help put the veteran biotech firm on a path to sustainable profitability.The contract is for the supply of lentiviral vectors used to generate CTL019, a new kind of treatment for hard-to-treat leukemia that is expected to reach the market this year.A U.S. advisory panel will discuss the case for approving CTL019 at a meeting...

Novartis receives EU approval for Cosentyx label update

Nov 22, 2017

ZURICH (Reuters) - Novartis said that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis.The label update includes 52 week data from the CLEAR study demonstrating the long-term superiority of Cosentyx versus Stelara (ustekinumab) in psoriasis, a common, non-contagious, auto-immune disease, the Swiss pharmaceutials company said on Thursday. (Reporting by Silke Koltrowitz)

FDA puts hold on Merck multiple myeloma trials after deaths

Nov 22, 2017

(Reuters) - Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.The rare setback for Keytruda sent Merck shares more than 1 percent lower.Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market. Bristol-Myers...

Top News
You May Need To Know

About Us

The Healthier Web delivers accurate and up-to-date health information through medical content and insights from experts. Feel the ‘ohm’ here in The Healthier Web.

Contact us: